Notice of NIDDK Participation in PAR-19-274, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)"
Notice Number:
NOT-DK-21-013

Key Dates

Release Date:

February 18, 2021

Related Announcements

PAR-19-274 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice informs potential applicants that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will participate in PAR-19-274, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" beginning with the June 5, 2021 application due date.

NIDDK will support evaluation of approaches that improve the effectiveness of healthcare, improve uptake of efficacious interventions in diverse populations and settings, reduce/eliminate disparities, and improve health equity for research areas within its mission. NIDDK strongly encourages potential applicants to contact program staff for assistance in the early stages of developing applications.

The following sections of PAR-19-274 have been modified (shown in bold italics) to reflect the NIDDK’s participation in this FOA:

Part 1. Overview Information
Components of Participating Organizations


National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Center for Complementary and Integrative Health (NCCIH)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers.  The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Research on Women’s Health (ORWH)


Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242, 93.399, 93.213, 93.865, 93.837, 93.172, 93.866, 93.273, 93.855, 93.856, 93.173, 93.121, 93.279, 93.853, 93.307, 93.361, 93.113, 93.839, 93.838, 93.233; 93.840, 93.846, 93.313, 93.847


Section VII. Agency Contacts

Scientific/Research Contact(s)
Pamela L. Thornton, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-6476
Email:pamela.thornton@nih.gov


Financial/Grants Management Contact(s)
Elizabeth Gutierrez
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8844
Email: gutierrezel@niddk.nih.gov


All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Pamela L. Thornton, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-6476
Email: pamela.thornton@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices